https://www.centerforbiosimilars.com/view/biosimilars-rheumatology-roundup-for-january-2023-podcast-edition
0
0
2/5/23 at 12:05pm
Organization
The Center for Biosimilars
Author
Skylar Jeremias
45 words
0
Comments
On this episode of Not So Different, we reminisced about the major biosimilar news to come out of the rheumatology field during January 2023, including the launch of the first Humira (adalimumab) biosimilar.
You are the first to view
Create an account
or login to join the discussion